How Stellate Ganglion Block (SGB) May Support Nerve Healing and Pain Relief – Insights from New Research
At AIMS, we regularly offer Stellate Ganglion Blocks (SGBs) as part of our integrative approach to managing complex pain and trauma-related conditions. While many patients have already experienced meaningful relief through this safe and minimally invasive technique, emerging research continues to deepen our understanding of how SGB may support the nervous system — not only by relieving pain, but by promoting healing at the cellular level.
Researchers used a spinal cord injury model in rats, a condition that often results in long-lasting neuropathic pain due to nerve damage. In the study, some rats received an SGB after their injury, while others did not.
The outcomes were striking. Rats that received an SGB experienced:
Improved Motor Recovery: They showed faster and more complete improvement in their ability to move.
Reduced Inflammation: Inflammatory markers such as IL-1β, IL-6, and TNF-α were significantly lower in spinal tissue following SGB treatment.
Decreased Pain Sensitivity: SGB-treated rats had higher pain thresholds, indicating a reduction in neuropathic pain.
Lower Rates of Cell Death: Apoptosis, or programmed nerve cell death, was reduced in the SGB group.
Restored Cellular Recycling (Autophagy): SGB enhanced autophagy, the process by which cells clear out damage — a crucial factor in nervous system repair.
Why Is This Relevant for Human Health?
Although this was an animal study, many of the same biological pathways apply to humans. The findings are especially relevant for conditions involving inflammation and nervous system overactivity, such as:
Post-injury or post-surgical neuropathic pain
Persistent sympathetic nervous system activation (commonly seen in trauma and PTSD)
Chronic pain syndromes such as CRPS
This study suggests that SGB may not only interrupt pain signals, but also help regulate the underlying inflammation and cellular dysfunction that often perpetuate chronic pain.
What We See at AIMS
At AIMS, we have already seen positive results using SGB to support patients with:
Post-traumatic stress and anxiety-related symptoms
Long COVID-related nervous system dysfunction
Complex regional pain syndrome (CRPS)
Postoperative or persistent nerve pain
This research adds valuable support to what we witness in clinical practice: SGB appears to offer more than symptom relief — it may help reset and rebalance the nervous system for long-term benefit.
Is SGB Right for You?
If you or someone you care about is struggling with neuropathic pain, chronic inflammation, or trauma-related nervous system symptoms, Stellate Ganglion Block may be a promising option. It’s a quick outpatient procedure with a strong safety profile and growing evidence of benefit.
Contact us at AIMS to schedule a consultation and explore whether SGB could support your recovery.
Mar . 10 . 2026 Kidney Cancer Association This is a guest post by Alena Guggenheim, N.D., Assistant Professor of Anesthesiology and Perioperative Medicine at the Oregon Health & Science University’s School of Medicine in Portland, Oregon. Dr. Guggenheim was diagnosed with a malignant sarcoma in late 2024 after discovering a large mass on her kidney. I had been feeling slightly off for a week, a subtle wobble in my vision, a quickening of my heart I couldn’t quite name. Then, one night at 3 a.m., I woke dripping in sweat, with the worst headache of my life. I tried to ...
Integrative Primary Care | Root-Cause Medicine | Whole-Person Healing We are honored and delighted to welcome Dr. Rachel Caplan-Erickson, ND, LAc to the AIMS Institute team. With over 14 years of clinical experience, Dr. Rachel brings a deeply integrative, root-cause approach to primary care that bridges modern diagnostics with time-honored healing traditions. Her work embodies what AIMS Institute stands for: comprehensive, compassionate, whole-person medicine. A Truly Integrative Approach to Primary Care Dr. Rachel is a licensed naturopathic physician and acupuncturist who provides comprehensive primary care through a uniquely integrative lens. She combines advanced laboratory testing and modern medical diagnostics with ...
Alka Christnacht1Therry Rose Eparwa1,2Emily Whinkin2*Sunil Aggarwal2,3 The postpartum period is notorious for rapid and profound changes for birthing individuals and their families. Significant shifts to hormonal and physical health, routines and family roles, and the salience of personal and community risk factors all contribute to potential psychiatric and psychological distress for parents, sometimes diagnosed as a postpartum mood or anxiety disorder (PMAD). Existing pharmacologic treatment modalities for PMADs do not comprehensively address the profound shifts of the postpartum period, often inadequate at reaching peak therapeutic efficacy in a shorter time frame, in patient accessibility, or offering sustained benefit. Ketamine assisted ...